Differential regulation of two types of intracellular calcium release channels during end-stage heart failure

Journal of Clinical Investigation

Volumn 95, Issue 2, 1995, Pages 888-894

  Go, Loewe O ^a   Moschella, Maria C ^a   Watras, James ^b   Handa, Kushal K ^a   Fyfe, Billie S ^a   Marks, Andrew R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; RYANODINE; RYANODINE RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CALCIUM CELL LEVEL; CHANNEL GATING; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; EXCITATION CONTRACTION COUPLING; FEMALE; HEART LEFT VENTRICLE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

EID: 0028809084     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/jci117739     Document Type: Article

References (45)

1. Parmley, W., K. Chatterjee, G. Francis, B. Firth, and R. Kloner. 1991. Congestive heart failure-new frontiers. West. J. Med. 154:427-441.
2. McKee, P., W. Castelli, P. McNamara, and W. Kannel. 1971. The natural history of congestive heart failure: the Framingham Study. N. Engl J. Med. 285:1441-1446.
3. Fleischer, S., and M. Inui. 1989. Biochemistry and biophysics of excitation-contraction coupling. Annu. Rev. Biophys. Chem. 18:333-364.
4. Callewaert, G. 1992. Excitation-contraction coupling in mammalian cardiac cells. Cardiovasc. Res. 26:923-932.
5. Fabiato, A. 1983. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am. J. Physiol. 245:C1-C14.
6. Furuichi, T., S. Yoshikawa, A. Miyawaki, K. Wada, N. Maeda, and K. Mikoshiba. 1989. Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature (Lond.). 342:32-38.
7. Marks, A., P. Tempst, C. Chadwick, L. Riviere, S. Fleischer, and B. Nadal-Ginard. 1990. Smooth muscle and brain inositol 1,4,5-trisphosphate receptors are structurally and functionally similar. J. Biol. Chem. 265:1-4.
8. Moschella, M., and A. Marks. 1993. Inositol 1,4,5-trisphosphate receptor expression in cardiac myocytes. J. Cell Biol. 120:1137-1146.
9. Berridge, M., and R. Irvine. 1989. Inositol phosphates and cell signalling. Nature (Lond.). 341:197-205.
10. Berridge, M. 1993. Inositol trisphosphate and calcium signalling. Nature (Lond.). 361:315-325.
11. Ehrlich, B., and J. Watras. 1988. Inositol 1,4,5-trisphosphate activates a channel from smooth muscle sarcoplasmic reticulum. Nature (Lond.). 336:583-586.
12. Hathaway, D., K. March, J. Lash, L. Adam, and R. Wilensky. 1991. Vascular smooth muscle - a review of the molecular basis of contractility. Circulation. 83:382-390.
13. Somlyo, A., M. Bond, A. Somlyo, and A. Scarpa. 1985. Inositol trisphosphate-induced calcium release and contraction in vascular smooth muscle. Proc. Natl. Acad. Sci. USA. 82:5231-5235.
14. Marks, A., P. Tempst, K. Hwang, M. Taubman, M. Inui, C. Chadwick, S. Fleischer, and B. Nadal-Ginard. 1989. Molecular cloning and characterization of the ryanodine receptor/junctional channel complex cDNA from skeletal muscle sarcoplasmic reticulum. Proc. Natl. Acad. Sci. USA. 86:8683-8687.
15. Otsu, K., H. Willard, V. Khanna, F. Zorzato, N. M. Green, and P.-H. MacLennan. 1990. Molecular cloning of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J. Biol. Chem. 265:13472-13483.
16. Takeshima, H., S. Nishimura, T. Matsumoto, H. Ishida, K. Kangawa, N. Minamino, H. Matsuo, M. Ueda, M. Hanaoka, T. Hirose, and S. Numa. 1989. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature (Lond.). 339:439-445.
17. Chadwick, C., A. Saito, and F. S. 1990. Isolation and characterization of the inositol trisphosphate receptor from smooth muscle. Proc. Natl. Acad. Sci. USA. 87:2132-2136.
18. Gwathmey, J., L. Copelas, R. McKinnon, F. Schoen, M. Feldman, W. Grossman, and J. Morgan. 1987. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ. Res. 61:70-76.
19. Mercadier, J., A. Lompre, P. Due, K. R. Boheler, J. B. Fraysse, C. Wisnewsky, P. D. Allen, M. Komajda, and K. Schwartz. 1990. Altered sarcoplasmic reticulum Ca2+-ATPase gene expression in the human ventricle during end-stage heart failure. J. Clin. Invest. 85:305-309.
20. Takahashi, T., P. Allen, A. Marks, A. Denniss, F. Schoen, W. Grossman, J. Marsh, and S. Izumo. 1992. Altered expression of genes encoding the Ca2+ regulatory proteins in the myocardium of patients with end-stage heart failure: Correlation with expression of the Ca2+-ATPase gene. Circ. Res. 71:1357-1365.
21. Arai, M., N. Alpert, D. MacLennan, P. Barton, and M. Periasamy. 1993. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ. Res. 72:463-469.
22. Brilliantes, A., P. Allen, T. Takahashi, S. Izumo, and A. Marks. 1992. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ. Res. 71:18-26.
23. Packer, M. 1992. Pathophysiology and treatment of chronic heart failure. Lancet. 340:88-95.
24. Dodd, D., J. Atkinson, R. Olson, S. Buck, B. Cusack, S. Fleischer, and R. Boucek Jr. 1993. Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model. J. Clin. Invest. 91:1697-1705.
25. Benevolensky, D., I. Moraru, and J. Watras. 1994. Micromolar calcium decreases affinity of inositol trisphosphate receptor in vascular smooth muscle. Biochem. J. 299:631-636.
26. Kentish, J., R. Barsotti, T. Lea, I. Mulligan, J. Patel, and M. Ferenczi. 1990. Calcium release from cardiac sarcoplasmic reticulum induced by photorelease of calcium or Ins(1,4,5)P3. Am. J. Physiol. 258:H610-H615.
27. Nosek, T., M. Williams, S. Ziegler, and R. Godt. 1986. Inositol trisphosphate enhances calcium release in skinned cardiac and skeletal muscle. Am J Physiol. 250:C807-C811.
28. Nakagawa, T., H. Okano, T. Furuichi, J. Aruga, and K. Mikoshiba. 1991. The subtypes of the mouse inositol 1,4,5-trisphosphate receptor are expressed in a tissue-specific and developmentally specific manner. Proc. Natl. Acad. Sci. USA. 88:6244-6248.
29. Hasenfuss, G., H. Reinecke, R. Studer, M. Meyer, B. Pieske, J. Holtz, C. Holubarsch, H. Posival, H. Just, and H. Drexler. 1994. Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium. Circ. Res. 75:434-442.
30. 2+-transporting ATPase, phospholamban and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 90:653-657.
31. Cory, R., L. McCutcheon, M. O'Grady, A. Pang, J. Geiger, and P. O'Brien. 1993. Compensatory downregulation of myocardial Ca channel in SR from dogs with heart failure. Am. J. Physiol. 264:H926-H927.
32. Handa, K., M. Moschella, B. Fyfe, and A. Marks. 1993. Regulation of calcium channel expression during heart failure. Circulation. 88(suppl I):I-624. (Abstr.)
33. Goldstein, R., S. Boccuzzi, D. Cruess, and S. Nattel. 1991. Diltiazem increases late-onset congestive heart failure in post-infarction patients with early reduction in ejection fraction. Circulation. 83:52-60.
34. Elkayum, V., J. Amin, A. Mehra, J. Vasquez, L. Weber, and S. Rahimtoola. 1990. A prospective, randomized double-blind cross-over study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation. 82:1954-1961.
35. Tazelaar, H., and W. Edwards. 1992. Pathology of cardiac transplantation: recipient hearts (chronic heart failure) and donor hearts (acute and chronic rejection). Mayo Clin. Proc. 67:685-696.
36. Chien, K., K. Knowlton, H. Zhu, and A. Chien. 1991. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB (Fed. Am. Soc. Exp. Biol.) J. 5:3037-3046.
37. Sadoshima, J., and S. Izumo. 1993. Signal transduction pathways of angiotensin II induced c-fos gene expression in cardiac myocytes in vitro: roles of phospholipid-derived second messengers. Circ. Res. 73:424-438.
38. Sadoshima, J., Y. Xu, H. Slayter, and S. Izumo. 1993. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:977-984.
39. Lovenberg, W., and R. Miller. 1990. Endothelin: a review of its effects and possible mechanisms of action. Neurochem. Res. 15:407-417.
40. Colucci, W. 1993. In situ assessment of α- and β-adrenergic responses in failing human myocardium. Circulation. 87(suppl VII):VII63-VII67.
41. Otani, H., H. Otani, and D. Das. 1988. α1-Adrenoreceptor-mediated phosphoinositide breakdown and inotropic response in rat left ventricular papillary muscles. Circ. Res. 62:8-17.
42. Aronson, R., and Z. Ming. 1993. Cellular mechanisms of arrhythmias in hypertrophied and failing myocardium. Circulation. 87(suppl VII):VH76-VII83.
43. Colquhoun, D., E. Neher, H. Reuter, and C. Stevens. 1981. Inward current channels activated by intracellular Ca in cultured cardiac cells. Nature (Lond.). 294:752-754.
44. 2+ in mammalian cardiac muscle. Nature (Lond.). 304:735-738.
45. 2+ release from cardiac sarcoplasmic reticulum. Pflugers Arch. 418:1-6.